Crescentis Capital board to review rights issue progress on Sep 29
- Crescentis Capital Limited board meeting scheduled for September 29, 2026
- Agenda includes reviewing progress on proposed rights issue fund raising
- Fund Raising Committee constituted on May 29, 2026 to oversee the process
- Proposal involves raising funds via equity shares on a rights basis
- Subject to regulatory and statutory approvals as deemed appropriate

*this image is generated using AI for illustrative purposes only.
Crescentis Capital Limited will convene a Board of Directors meeting on Tuesday, September 29, 2026. The primary agenda is to review updates and progress regarding a proposed fund raising exercise via equity shares on a rights basis.
The Board will assess the work undertaken by the Fund Raising Committee, which was constituted during the Board Meeting held on May 29, 2026. This committee was tasked with evaluating the proposal for raising funds through rights issues, subject to necessary regulatory and statutory approvals.
Meeting Agenda and Scope
The intimation filed with BSE Limited under Regulation 29 of the SEBI Listing Regulations outlines the specific focus of the upcoming session. The Board intends to examine the status of the rights issue proposal as permitted under applicable law.
Key aspects of the meeting include:
- Reviewing progress made by the Fund Raising Committee since its formation in May 2026.
- Considering the proposal for raising funds by way of equity shares on a rights basis.
- Evaluating regulatory and statutory approvals required for the transaction.
- Addressing any other business brought before the Board with the Chair's permission.
Regulatory Context
This disclosure serves as prior intimation pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company, formerly known as Som Datt Finance Corporation Limited, continues to operate under its current corporate structure while pursuing capital market strategies.
The meeting date has been fixed for late September 2026, providing a clear timeline for stakeholders to anticipate further disclosures regarding the capital structure changes.
Historical Stock Returns for Crescentis Capital
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.20% | -1.85% | -3.21% | -18.13% | -26.29% | +156.41% |
What specific capital allocation strategy will Crescentis Capital pursue once the rights issue proceeds are secured?
How might the dilution from the rights issue impact existing shareholders' voting power and earnings per share?
What is the anticipated timeline for receiving final SEBI and statutory approvals following the board's review?
































